Doctor Janet Leeds
South San Francisco (United States of America)
Physiologically-based pharmacokinetic (PBPK) model predicted versus observed effect of Child Pugh mild and moderate hepatic impairment on betrixaban pharmacokinetics
Event: ESC Congress 2018
Topic: Anticoagulants
Session: Optimal surrogate endpoints of drug response
Analysis of patient characteristics as covariates potentially affecting pharmacokinetics, efficacy, or safety of betrixaban in the APEX study
Event: ESC Congress 2017
Topic: Primary cardiovascular prevention: interventions and outcomes
Session: Best Posters in prevention, interventions and outcomes
ESC 365 is supported by
